Single Lipiflow Treatment to Reduce Pharmacologic Burden in DED

NAEnrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

February 28, 2024

Study Completion Date

September 1, 2024

Conditions
MGD-Meibomian Gland Dysfunction
Interventions
DEVICE

Thermal Vectored Pulsation

The LipiFlow® (Johnson \& Johnson Vision, USA) Thermal Pulsation System, also known as vectored thermal pulsation, is a treatment that applies localized heat and pressure to the meibomian glands lining the eyelids. The device consists of a console connected to single-use, sterile devices applied to each eye known as activators. The activator includes an eye warmer with a large lens that gently sits on the conjunctiva of each eye. The activator cups the upper and lower eyelid and applies regulated, outward heat to the surface of the palpebral conjunctiva with an air bladder that intermittently provides directional, controlled massage of the eyelids to promote expression of the liquified contents.

Trial Locations (1)

57049

Dunes Eye Consultants, Dakota Dunes

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Johnson & Johnson

INDUSTRY

lead

Dunes Eye Consultants

OTHER